CDDOM Oneome Rightmed Depression Study

Status Not yet recruiting

Clinical Trial Summary

Clinical Trial Description

In this study, we hypothesize PGx guided testing can improve outcomes related to treatment of moderate and severe depression among El Rio Community Health patients. We anticipate patients randomized to the OneOme RightMed® PGx test will demonstrate a greater improvement of depressive symptoms and will have a higher proportion of subjects reporting response and remission than those receiving standard care. Our purpose is to determine the effectiveness and feasibility of implementing a pharmacogenomic (PGx) approach to prescribing antidepressant medication in an underserved, community health center patient population. Primary Outcomes: 1. Changes in patient depressive ratings will be the primary endpoint in this study. The primary outcome will be measured using the validated Patient Health Questionnaire (PHQ-9) depression rating scale, administered verbally to participants. Depression response and remission rates (proportion of subjects achieving or not achieving), in the control and intervention arm will be directly compared at baseline, 2, 4, 8, and 12 weeks. 2. Patient progression from primary care to El Rio behavioral health (BH) specialty care will also be monitored in this study. We will directly compare the proportion of subjects in the control and intervention arm requiring BH consultation at any point in the study. Secondary Outcomes: 1. Medication changes - Number of antidepressant medication changes and/or dose adjustments per subject from baseline to study endpoint. 2. Medication congruence - Alignment of physicians to RightMed test recommendations in control and intervention arm (guided vs unguided) and time to achieve optimal medication selection (green bin). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04909749
Study type	Interventional
Source	University of Arizona
Contact	Lawrence Mandarino, PhD
Phone	5206266485
Email	mandarino@deptofmed.arizona.edu
Status	Not yet recruiting
Phase	N/A
Start date	June 2021
Completion date	June 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04122482` - An Online Course for Improving Knowledge and Access to Mental Health Accommodations in Canadian Enterprises	N/A
Completed	`NCT04085861` - Mental Health in Dancers; an Intervention Study	N/A
Recruiting	`NCT06060210` - Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion	Phase 4
Active, not recruiting	`NCT04588883` - Strengthening Families Living With HIV in Kenya	N/A
Recruiting	`NCT06065787` - NeuroGlove Anxiety and Depression Study	N/A
Active, not recruiting	`NCT04583891` - Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design	N/A
Completed	`NCT05554042` - Kintsugi Voice Device Study
Not yet recruiting	`NCT06162624` - Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons	N/A
Not yet recruiting	`NCT06430853` - Psychobiological Interventions in Pregnancy	N/A
Completed	`NCT02954250` - Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide	Early Phase 1
Recruiting	`NCT05647499` - Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study	N/A
Completed	`NCT03980873` - Cognitive-Behavioral Therapy for Young Adult Lesbian, Gay and Bisexual: Transdiagnostic Minority Stress Approach	N/A
Completed	`NCT04422327` - The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome	Phase 1/Phase 2
Completed	`NCT05368155` - Chronic Pelvic Pain and Education Skills Training for Women Veterans	N/A
Completed	`NCT05455905` - Voice Biomarkers Predictive of Depression and Anxiety
Completed	`NCT03272516` - Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients	N/A
Not yet recruiting	`NCT05493865` - Parent-Child Single-Session Growth Mindset Intervention on Adolescent Depression and Anxiety Problems	N/A
Not yet recruiting	`NCT06027047` - Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)
Not yet recruiting	`NCT05535101` - Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder	N/A
Recruiting	`NCT04418115` - Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.